Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Spyre Therapeutics, Inc.

NASDAQ: SYRE · Life Sciences · 6 alerts · CIK 1636282

Share price
$99.37Close, Nov 16
Market cap
$9.44B
Shares outstanding
94.97MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Spyre Therapeutics, Inc. filings on SEC EDGAR ↗

8:00 AM ET 8-K
Capital Raise

Spyre Therapeutics Capital Raise of $350M

Spyre Therapeutics entered into an underwriting agreement for a public offering of 4,117,648 shares of common stock at $85.00 per share, expected to raise gross proceeds of approximately $350.0 million. The company intends to use the proceeds to advance its clinical programs in gastroenterology, rheumatology, and dermatology, including Phase 3 readiness and a new program for hidradenitis suppurativa.

Value
$350M
Counterparty
Jefferies LLC, TD Securities (USA) LLC, Leerink Partners LLC and Stifel, Nicolaus & Company, Incorporated

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.